Preimplantation Genetic Testing Market Report 2024 (Global Edition)

Global Preimplantation Genetic Testing Market Report 2024 Market Size Split by Test Type (Diagnostics, Screening), by End User (Hospitals, Diagnostic Labs, Research & Academic Institutions, Specialize...

Preimplantation Genetic Testing Market Report Description

We have various report editions of Preimplantation Genetic Testing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Preimplantation Genetic Testing Market Insights Video

Competitive Landscape of the Preimplantation Genetic Testing Market

Several companies are vying for market share in the Preimplantation Genetic Testing industry through strong marketing campaigns, strategic alliances, and innovative product development. The industry's major participants are well-known medical device producers, specialized producers of Preimplantation Genetic testing, and up-and-coming startups hoping to upend the market with creative solutions.

October 2022: HelpCureHD and Genomic Prediction are using preimplantation genetic testing to assist couples who may be at risk of developing Huntington's disease (HD) in screening for the condition. HD is a genetic brain illness for which there is presently no known treatment. (Source:https://www.lifeview.com/20221025-GP_HelpCureHD.html) April 2022: Cell-free DNA testing is a field that Natera, Inc. led globally. Results from extensive real-world research have been made public, showing that patients with chronic kidney disease (CKD) can obtain favorable genetic results with a high yield rate when using the company's RenasightTM test. (Source:https://www.natera.com/company/news/large-real-world-study-with-renasight-genetic-test-highlights-high-diagnostic-yield-for-patients-with-chronic-kidney-disease/)

Top Companies Market Share in Preimplantation Genetic Testing Industry: (In no particular order of Rank)

• Illumina
• Inc.
• Thermo Fisher Scientific Inc.
• Agilent Technologies
• Inc.
• Revvity
• The Cooper Companies
• Inc.
• Abbott
• Takara Bio Inc.
• Qiagen
• Vitrolife
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Preimplantation Genetic Testing Market

Which Region Dominates the Preimplantation Genetic Testing Market in 2024?

According to Cognitive Market Research, North America led the market in 2024, accounting for almost 40% of worldwide sales. Due to the growing population of the nation and the amount of money spent on health care. According to data from the Department of Health and Human Services, 489 fertility clinics in the US provide assisted reproductive technology (ART) services as of 2019. Massachusetts, Columbia, and New Jersey have the highest rates of newborns resulting from assisted reproductive technology among other states. Furthermore, it is projected that increased funding for preimplantation genetic testing will result from a rising understanding of the value of healthy embryos in nations with poorer living standards.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific stands out as the fastest-growing region in the Preimplantation Genetic Testing market. The main countries in the area that are still making strides in other medical specialties, as well as reproductive health, include China and Japan. PGT usage has increased in this region due to the high adoption rate of IVF, and rising public awareness is anticipated to enhance revenue creation in the local market. Furthermore, the adoption of these treatments in this region would be aided in the near future by developing economies like China and India, as well as by the existence of regulatory agencies to oversee issues related to reproductive health. As an example, Peking Jabrehoo Med Tech Co. Ltd. obtained marketing permission from the NMPA in China in November 2021 for its preimplantation genetic testing for aneuploidy.

The current report Scope analyzes Preimplantation Genetic Testing Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

North America Preimplantation Genetic Testing Market

According to Cognitive Market Research, the global Preimplantation Genetic Testing market size was estimated at USD 421.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 168.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Preimplantation Genetic Testing market with a market size of USD 132.93 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. The US is predicted to see growth in PGT despite a robust current industry because of the previously cited variables, including rising incidence of infertility and growing public awareness of genetic abnormalities.
• The Canadian Preimplantation Genetic Testing market had a market share of USD 20.22 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. Fertility treatments, including IVF cycles, are partially covered by Canada's universal healthcare program. Couples looking for genetic testing may find PGT to be a more accessible choice due to this financial support.
• The Mexico Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 15.33 million in 2024.

Europe Preimplantation Genetic Testing Market

According to Cognitive Market Research, the global Preimplantation Genetic Testing market size was estimated at USD 421.2 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 126.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.0% from 2024 to 2031.

• The United Kingdom Preimplantation Genetic Testing market had a market share of USD 21.23 million in 2024 and is projected to grow at a CAGR of 5.8% during the forecast period. In vitro fertilization (IVF) is a well-established sector in the UK, and PGT is becoming more and more valued as an add-on service for couples undergoing IVF cycles.
• The France Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 11.63 million in 2024.
• According to Cognitive Market Research, the German Preimplantation Genetic Testing market size was valued at USD 25.02 million in 2024 and is projected to grow at a CAGR of 5.2% during the forecast period. German regulations guarantee strict quality control measures for PGT operations. As a result, patients and healthcare professionals have more faith and confidence in the technology.
• The Italy Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 4.4% during the forecast period, with a market size of USD 10.87 million in 2024.
• The Russian Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 19.59 million in 2024.
• The Spain Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 4.1% during the forecast period with a market size of USD 10.36 million in 2024
• The Luxembourg Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 3.92 million in 2024.
• The Portugal Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 2.65 million in 2024.
• The Greece Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 1.52 million in 2024.
• Rest of Europe's Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 19.59 million in 2024.

Asia Pacific Preimplantation Genetic Testing Market

According to Cognitive Market Research, the global Preimplantation Genetic Testing market size was estimated at USD 421.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 96.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Preimplantation Genetic Testing market size was valued at USD 43.59 million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period. Greater access to PGT treatments is being made possible by the fast-growing number of fertility clinics in China.
• The Japan Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 13.37 million in 2024.
• The India Preimplantation Genetic Testing market had a market share of USD 11.63 million in 2024 and is projected to grow at a CAGR of 10.3% during the forecast period. As a result of India's expanding economy and increased disposable means, couples are now able to explore modern reproductive procedures like PGT.
• The South Korean Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 9.69 million in 2024.
• The Australian Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 5.04 million in 2024.
• The Southeast Asia Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 6.68 million in 2024.
• The Rest of Asia Pacific Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 8.3% during the forecast period, with a market size of USD 6.88 million in 2024.

South America Preimplantation Genetic Testing Market

According to Cognitive Market Research, the global Preimplantation Genetic Testing market size was estimated at USD 421.2 Million, out of which Latin America market of more than 5% of the global revenue with a market size of USD 21.06 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Preimplantation Genetic Testing market size was valued at USD 9.01 million in 2024 and is projected to grow at a CAGR of 6.5% during the forecast period. In Brazil, the idea of individualized medicine is becoming more popular. By providing couples with personalized genomic information for well-informed family planning, PGT supports this trend.
• Argentina's Preimplantation Genetic Testing market had a market share of USD 3.54 million in 2024 and is projected to grow at a CAGR of 6.8% during the forecast period. A well-established bioethics framework in Argentina governs genetic testing. This emphasis on moral behavior can guarantee that PGT is applied responsibly.
• Colombia Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 1.87 million in 2024.
• Peru Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD 1.73 million in 2024.
• Chile's Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 1.52 million in 2024.
• The Rest of Latin America's Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 3.39 million in 2024.

Middle East and Africa Preimplantation Genetic Testing Market

According to Cognitive Market Research, the global Preimplantation Genetic Testing market size was estimated at USD 421.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 8.42 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

• The GCC Countries Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 3.61 million in 2024. The GCC nations are renowned for making large expenditures in cutting-edge technologies across a range of industries. This tendency may also apply to PGT, encouraging the use of more recent and effective PGT methods.
• The Egypt Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 0.88 million in 2024.
• The South African Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 1.33 million in 2024. In South Africa, the market for private health insurance is expanding. Future insurance plans that incorporate PGT may greatly improve accessibility for individuals who are covered.
• The Turkey Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 0.72 million in 2024.
• The Nigeria Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 0.88 million in 2024.
• The Rest of the MEA Preimplantation Genetic Testing market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 0.99 million in 2024.

Preimplantation Genetic Testing Market Analysis

Preimplantation Genetic Testing Market Test Type Segment Analysis

According to Cognitive Market Research, Diagnostics is the dominating category. Due to growing knowledge of genetic abnormalities and the need to ensure safe births, there is an increasing demand for Preimplantation Genetic Testing (PGT) diagnoses. Preimplantation Genetic Diagnosis (PGD), which diagnoses particular genetic illnesses, and Preimplantation Genetic Screening (PGS), which detects chromosomal abnormalities, are the main types driving this need. The increased demand for these diagnostic tests in the PGT market is mostly due to the aging of mothers, improvements in genetic technologies, and the expanding acceptance of in vitro fertilization.

Screening is the fastest-growing category in the Preimplantation Genetic Testing market. Preimplantation genetic testing screening, or PGT-S, is becoming more and more popular as people seek to have safe children and are becoming more aware of genetic anomalies. IVF couples especially desire PGT-S since it increases the likelihood of successful pregnancies by assisting in the identification of chromosomal abnormalities prior to implantation. Growing demand for PGT-S is driven by factors such as increased maternal age, genetic problem prevalence, and technological developments in genetic testing; therefore, PGT-S is a crucial component of services for reproductive health.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Preimplantation Genetic Testing Industry. Request a Free Sample PDF!

Preimplantation Genetic Testing Market End User Segment Analysis

According to Cognitive Market Research, the dominating category is Hospitals. The expansion of the category can be attributed to various factors, including a rise in patient volume, enhanced healthcare facilities, and the existence of both public and private hospitals providing in vitro fertilization services. Due to the extremely advanced technology that hospitals offer, most couples seeking fertility therapy go there for additional therapies. Furthermore, an increase in testing rates in hospital settings is anticipated due to the growth in research conducted there. Furthermore, it is anticipated that in the coming years, the hospital category will develop at the quickest rate.

The fastest-growing category in the Preimplantation Genetic Testing market is Research & Academic Institutions. In research and academic institutions, the need for preimplantation genetic testing, or PGT, is rising quickly. In an effort to discover novel reproductive technologies, increase IVF success rates, and further research on genetic abnormalities, these organizations are investing more and more in PGT. Programs in genetics, embryology, and reproductive medicine depend heavily on PGT because it offers insightful information about the genetics and viability of embryos. In these academic environments, the need for PGT is further increased by government grants and financing for genetic research.

The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Preimplantation Genetic Testing market report 2024 Edition by contacting our team.

Preimplantation Genetic Testing Application Segment Analysis

Preimplantation Genetic Testing Market Application Segment Analysis

According to Cognitive Market Research, the dominating category is Embryo HLA Typing for Stem Cell Therapy. Demand for embryo HLA typing in the Preimplantation Genetic Testing (PGT) industry is rising due to applications including stem cell therapy. In this particular application, compatibility with the Human Leukocyte Antigen (HLA) is screened in embryos. This is an important step for families hoping to produce a kid who can donate stem cells to a sibling suffering from a life-threatening illness. By ensuring a close genetic match, HLA typing reduces the possibility of rejection and raises the success rates of stem cell transplantation. The increasing frequency of genetic abnormalities, the development of personalized medicine techniques in the treatment of complicated diseases, and technological developments in genetic testing are driving this emerging segment within the PGT market.

The fastest-growing category in the Preimplantation Genetic Testing market is IVF Prognosis. The IVF Prognosis application in the Preimplantation Genetic Testing (PGT) market uses genetic testing to evaluate the quality of the embryos and forecast the outcome of IVF treatments. PGT enhances the selection of viable embryos and raises the possibility of successful pregnancies by assisting in the detection of genetic and chromosomal abnormalities disorders in embryos prior to implantation. With assisted reproductive technology, this application improves patient results and satisfies the need for customized fertility treatments.

• Embryo HLA Typing for Stem Cell Therapy
• Late-Onset Genetic Disorders
• IVF Prognosis
• Inherited Genetic Diseases
• Other

Preimplantation Genetic Testing Technology Segment Analysis

Preimplantation Genetic Testing Market Technology Segment Analysis

According to Cognitive Market Research, the dominating category is PCR-based. A significant portion of the segment's high market share can be attributed to PCR tests' high accuracy, cost-effectiveness, and high market penetration. Additionally, PCR increases the likelihood of obtaining many copies of a certain genomic region, which increases the possibility of finding any chromosomal abnormalities in the sample. For all kinds of genetic diagnostics, PCR is a sensitive and specific method.

The fastest-growing category in the Preimplantation Genetic Testing market is NGS-based. Because next-generation sequencing tests can sequence a lot of DNA quickly and with greater precision than previous methods, they are a good choice. Furthermore, NGS may now detect a wide spectrum of other chromosomal abnormalities due to technological developments.

• PCR-based
• NGS-based
• FISH-based
• SNP-based
• CGH-based

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion